Effectiveness and safety of monoclonal antibodies for SARS-CoV-2: retrospective analysis of patients treated in the Varese Hospital

Attardo, T. M.; Pagani, P.; Turchetti, A.; Fazio, M.; Galfrascoli, E.; Galli, D.; Cavi, R.; Tuzi, A.; Dalla Gasperina, D.; Dentali, F.

Attardo, T. M.; Pagani, P.; Turchetti, A.; Fazio, M.; Galfrascoli, E.; Galli, D.; Cavi, R.; Tuzi, A.; Dalla Gasperina, D.; Dentali, F..

Italian Journal of Medicine ; 16(SUPPL 1):7, 2022.

Article in English | EMBASE | ID: covidwho-1912880

Keywords

bamlanivimab; casirivimab plus imdevimab; etesevimab; sotrovimab; adult; adverse drug reaction; body mass; cardiovascular disease; chronic lung disease; comparative effectiveness; conference abstract; coronavirus disease 2019; diabetes mellitus; drug combination; drug safety; drug therapy; end stage renal disease; female; hospital patient; hospitalization; human; immune deficiency; major clinical study; male; middle aged; nonhuman; outcome assessment; outpatient; pneumonia; retrospective study; serology; Severe acute respiratory syndrome coronavirus 2; side effect

Search on Google

XML

Collection: Databases of international organizations Database: EMBASE Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Vaccines Language: English Journal: Italian Journal of Medicine Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML